FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

May 23, 2024

NewsDirect

Innoveren Scientific’s (OTCMKTS: IVRN) 510(k) Submission Sparks A New Hope For Patients Living With Chronic Non-Healing Wounds

March 8, 2024